If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position
Nano-X Imaging (NASDAQ: NNOX), DermTech (NASDAQ: DMTK), and Viking Therapeutics (NASDAQ: VKTX) are healthcare growth stocks with plenty of potential, little revenue, and a boatload of risk.
Share prices of Nano-X are up more than 150% this year, DermTech is up more than 70%, and Viking's shares are up 138%. The problem I have with all three companies is that while they offer disruptive products that could cause a paradigm shift in their industries, much of that potential has already been priced into their stocks. Add in the fact that none of the companies is profitable and you have a very real potential to see these inflated share prices come back to Earth in a painful deflation.
Let's look at why owners of these three stocks might want to rethink their positions.
Source Fool.com
Viking Therapeutics Inc Stock
Our community is currently high on Viking Therapeutics Inc with 5 Buy predictions and 0 Sell predictions.
With a target price of 100 € there is a hugely positive potential of 74.64% for Viking Therapeutics Inc compared to the current price of 57.26 €.